Elixhauser合并症指数对全髋关节置换术中破坏性出血的预测价值:对结局与费用的影响
基于2019年全国医疗数据库109,482例初次全髋关节置换患者,破坏性出血发生率为6.0%。按Elixhauser合并症指数分组后,合并症负担越高出血风险越高(ECI=2时OR=1.48,随负担增加至OR=3.81)。破坏性出血与更高总费用、更长住院时间和更高90天再入院率相关。
要点
- 109,482例初次全髋关节置换患者中破坏性出血发生6,586例(6.0%)。
- 女性与Medicare保险覆盖与更高出血风险相关(P<0.01)。
- 破坏性出血与更高费用、更长住院及更高90天再入院率相关。
核心结论
- 合并症负担更高的患者在全髋关节置换后更可能发生破坏性出血,且与更差的短期结果和明显更高的资源利用相关。
研究设计与样本
- 队列研究,使用全国医疗数据库识别2019年接受初次全髋关节置换的患者109,482例。
- 按Elixhauser合并症指数(ECI,范围0至≥6)分组,采用多变量逻辑回归分析破坏性出血的可能关联,并给出每个ECI的95%置信区间和比值比。
- 采用广义线性模型评估破坏性出血对住院时间、90天再入院率和总费用的影响。
主要发现
- 109,482例接受全髋关节置换的患者中,破坏性出血发生于6,586例(6.0%)。
- 女性和Medicare保险覆盖与更高出血风险相关(P<0.01)。
- 随着合并症负担增加,破坏性出血风险从ECI=2的OR=1.48(95%CI 1.23至1.78,P<0.001)升至OR=3.81(95%CI 2.85至5.10,P<0.001)。
- 破坏性出血与更高总费用相关(ECI>6时为34,700美元 vs 23,500美元,P<0.001)。
- 破坏性出血与更长住院时间相关(ECI≥6时为6.0天,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With an estimated one million cases per year anticipated by 2030, total hip arthroplasty (THA) is a popular and successful treatment for end-stage hip osteoarthritis. The objectives of this study were to: (1) measure the incidence of disruptive bleeding; (2) determine the demographics of patients and the burden of Elixhauser comorbidity related to disruptive bleeding; and (3) assess the effect of disruptive bleeding on health care utilization (inpatient costs, hospital lengths of stay, and 90-day readmission rates). METHODS: In this cohort study, patients who had primary THA in 2019 were identified using a national health care database. Multivariate logistic regressions were used to examine possible associations with disruptive bleeding after patients were grouped by Elixhauser Comorbidity Index (ECI), which ranged from 0 to ≥ 6. Both 95% confidence intervals (CIs) and odds ratios (ORs) were presented for every ECI. Generalized linear models were used to assess the effects of disruptive bleeding on hospital lengths of stay, 90-day readmission rates, and overall expenses. RESULTS: Disruptive hemorrhage occurred in 6,586 (6.0%) of the 109,482 patients receiving THA. Higher bleeding risk was linked to women and Medicare coverage (P < 0.01). For instance, the risks of disruptive bleeding rose from OR = 1.48 (95% CI 1.23 to 1.78, P < 0.001) for ECI = 2 to OR = 3.81 (95% CI 2.85 to 5.10, P < 0.001) as the comorbidity burden increased. Disruptive bleeding was linked to higher overall expenses ($34,700 versus $23,500 for ECI > 6; P < 0.001), longer hospital stays (6.0 days for ECI ≥ 6; P < 0.001), and higher 90-day readmissions (18.5 versus 10.2% for ECI = 5; P < 0.001). CONCLUSIONS: Patients who had higher comorbidity burdens are more likely to experience disruptive hemorrhage following THA, which is linked to worse short-term results and noticeably higher resource utilization.
引用
- Ng MK, Mont MA, Afolabi M, et al. The Elixhauser Comorbidity Index as a Predictor of Disruptive Bleeding in Total Hip Arthroplasty: Impact on Outcomes and Costs. J Arthroplasty. 2025. PMID: 41110645. doi:10.1016/j.arth.2025.10.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。